Top compounds associated with response to CHAD


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.2 0.0003
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.11 0.0005
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA neratinib CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA parbendazole CTRPv2 pan-cancer AAC -0.1 0.0007
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.14 0.0009
Download CSV